SCHEMBL8670587

SCHEMBL8670587

Nc1cccc([CH]Cc2cccc(N)c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.48
MAOB P27338 4/20 0.48
MAOA P21397 3/20 0.48
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.43
GFER P55789 1/20 0.43
CYP3A4 P08684 1/20 0.42
CASP1 P29466 1/20 0.42
RECQL P46063 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
AKR1B1 P15121 1/20 0.36
ALDH1A1 P00352 2/20 0.35
CA12 O43570 1/20 0.35
CA7 P43166 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2184383 0.82 MAOB (0.43) CYP19A1MAOBMAOAMAPTCYP3A4
SCHEMBL2183578 0.82 CYP19A1 (0.43) CYP19A1MAOBMAOANPC1MAPT
SCHEMBL12470562 0.81 ALDH1A1 (0.58) CYP19A1NPC1ALDH1A1TDP1
SCHEMBL8321871 0.77 MAOB (0.60) CYP19A1MAOBMAOANPC1MAPT
SCHEMBL8038746 0.77 CYP19A1 (0.54) CYP19A1MAOBMAOANPC1MAPT
SCHEMBL1935522 0.77 MAOB (0.54) CYP19A1MAOBMAOACYP3A4CASP1
SCHEMBL2184106 0.77 ALDH1A1 (0.44) CYP19A1MAOBMAOANPSR1ALDH1A1
SCHEMBL2184753 0.77 NPSR1 (0.47) CYP19A1MAOBMAOANPSR1CA1
SCHEMBL8818539 0.76 MAOB (0.48) CYP19A1MAOBMAOAMAPTCYP3A4
SCHEMBL19860765 0.76 MAOB (0.58) CYP19A1MAOBMAOANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed